Protalix BioTherapeutics, Inc.
PLX · AMEX
Bulios Fair Price
$1.46
48.0% downside
Trenutna cena
$2.81
Po podatkih Bulios Fair Price je delnica PLX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Protalix BioTherapeutics, Inc. (PLX) is a biotechnology company based in Israel, specializing in the development and production of biotechnology-based drugs. With a primary focus on research and development of drugs for rare diseases and genetic disorders, Protalix BioTherapeutics is a recognized player in the field of biologic therapeutics. The company is an innovative leader in the field of recombinant proteins and utilizes plant cell technology to produce drugs with higher efficacy and lower costs. Protalix BioTherapeutics aims to collaborate with pharmaceutical companies and biotechnology partners worldwide to bring new drugs to market and improve healthcare for patients suffering from rare diseases. Protalix BioTherapeutics, Inc. (PLX) shares could be suitable for investors seeking investment opportunities in biotechnology and drugs for rare diseases.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Dror Bashan
Employees
226
Headquarters
Hackensack
Prihajajoči dogodki
Earnings
Upcoming earnings report